In Vitroandin VivoEvaluation of the Efficacy of Bovine Colostrum against Human Rotavirus Infection
Author(s) -
Mizuho Inagaki,
Mayumi Yamamoto,
Xijier,
Cairangzhuoma,
Kenji Uchida,
Hiroshi Yamaguchi,
Mihoko Kawasaki,
K Yamashita,
Tomio Yabe,
Yoshihiro Kanamaru
Publication year - 2010
Publication title -
bioscience biotechnology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.509
H-Index - 116
eISSN - 1347-6947
pISSN - 0916-8451
DOI - 10.1271/bbb.90862
Subject(s) - colostrum , in vivo , rotavirus , potency , in vitro , diarrhea , inoculation , virology , biology , microbiology and biotechnology , virus , immunology , medicine , antibody , biochemistry
We found that skimmed and concentrated bovine late colostrum (SCBLC) obtained from normal cows at 6-7 d after parturition exhibited high potency in inhibiting replication of human rotavirus (HRV) in vitro. Furthermore, prophylactic oral administration of SCBLC once before inoculation of HRV prevented the development of diarrhea in suckling mice in vivo. SCBLC from normal cows might be useful in the prevention of HRV-induced severe gastroenteritis in immunocompromised hosts.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom